Academic Journals Database
Disseminating quality controlled scientific knowledge

Evaluation of flunixin meglumine genotoxicity using in vitro and in vivo/in vitro micronucleus test

Author(s): Aydin S.A. | Keles Üstüner O.

Journal: Acta Veterinaria
ISSN 0567-8315

Volume: 59;
Issue: 5-6;
Start page: 601;
Date: 2009;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: cytochalasin-B | flunixin meglumine | micronucleus | mice | peripheral lymphocytes

The aim of this study was to investigate the genotoxic effects of flunixin meglumine on mice peripheral lymphocytes by in vitro and in vivo/in vitro cytokinesis block micronucleus tests (CBMN). Flunixin meglumine was used at concentrations of 25, 50 and 100 μg/mL for the in vitro assay and 50, 75 and 100 mg/kg for the in vivo/in vitro assay. Mice were treated intraperitonally twice with a 24 h interval and sacrificed 6 h after the last dose. Cardiac blood was taken and added to the cultures for the in vivo/in vitro test. 21 h after the addition of the test compound for the in vitro test, and after the initiation of incubation for in vivo/in vitro test cytokinesis was blocked with the addition of cytochalasin-B and 20 h later the cultures were harvested. In both test systems, a negative and a positive control mitomycin C (MMC) were also included. The micronucleated binuclear cell (MNBN) frequencies increased after both treatments, however, the differences between the treated cells and the control groups were found to be statistically significant only for the in vitro treatment. The increase was in a dosedependent manner, significant elevations of MNBN cell (p
Why do you need a reservation system?      Affiliate Program